文献速递胃肠外科围术期管理与 ERAS

胃癌胃切除与内镜切除术后长期生存:全国真实世界数据

Long-Term Survivorship after Gastrectomy or Endoscopic Resection for Gastric Cancer Using Nationwide Real-World Data.
PubMed 文献 · J Am Coll Surg · 2025-09-16

基于韩国国民健康保险2002-2020年数据,按年龄、性别、CCI、保费四分位和治疗年份2:1匹配胃切除与内镜切除的胃癌生存者共74,367例(胃切除49,578例,内镜切除24,789例),比较15年主要不良心血管事件(MACE)和慢性病生存情况。胃切除组高血压、缺血性心脏病、心力衰竭、脑血管病和肥胖相关癌症发生率更低,MACE-3和MACE-6风险更低,但呼吸系统疾病死亡风险更高。

要点

  • 胃切除组高血压、缺血性心脏病、心衰、脑血管病及肥胖相关癌症发生率均低于内镜切除组。
  • 胃切除组MACE-3和MACE-6风险更低(HR 0.86, p<0.001)。
  • 胃切除组呼吸系统疾病死亡风险更高(HR 1.37, p<0.001)。

核心结论

  • 胃切除组较内镜切除组MACE风险更低、肥胖相关癌症发病和死亡更低、糖尿病或高血压医疗费用更低,但呼吸系统疾病死亡风险更高。

研究设计与样本

  • 回顾性匹配队列研究,使用韩国国民健康保险2002-2020年数据,按年龄、性别、Charlson Comorbidity Index、保险费用四分位和治疗年份2:1匹配胃切除与内镜切除患者。
  • 共纳入74,367例胃癌生存者,胃切除组49,578例,内镜切除组24,789例。

主要发现

  • 胃切除组高血压发生率更低(HR 0.53, p<0.001;11,757例事件)。
  • 胃切除组缺血性心脏病(HR 0.80, p<0.001;4,740例事件)、心力衰竭(HR 0.77, p<0.001;5,580例事件)、脑血管病(HR 0.78, p<0.001;6,013例事件)发生率更低。
  • 胃切除组肥胖相关癌症发生率更低(HR 0.74, p<0.001;1,500例事件),肥胖相关癌症死亡风险更低(HR 0.74, p<0.001),但呼吸系统疾病死亡风险更高(HR 1.37, p<0.001)。
  • 胃切除组MACE-3和MACE-6风险更低(HR 0.86, p<0.001)。
  • 治疗后前10年高血压和糖尿病年均医疗费用胃切除组更低($90.3 ± 1.9 vs $118.4 ± 2.5, p<0.001)。

临床怎么用

  • 胃切除术后长期随访应关注呼吸系统疾病相关死亡风险,同时继续管理心血管代谢风险。
  • 内镜切除术后患者需更积极监测高血压、糖尿病、缺血性心脏病、心力衰竭、脑血管病及肥胖相关癌症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nutritional deficiency and weight loss after gastrectomy are major challenges for gastric cancer survivorship, yet appropriate weight reduction can prevent chronic metabolic or cardiovascular diseases. This study evaluated long-term survivorship with chronic diseases in gastric cancer survivors who underwent gastrectomy vs endoscopic resection (ER) in the Korean population. STUDY DESIGN: Korean National Health Insurance data of patients with gastric cancer treated by gastrectomy or ER between 2002 and 2020 were matched 2:1 by age, sex, Charlson Comorbidity Index, insurance premium quartiles, and year of treatment. The 15-year survivorship with major adverse cardiovascular events (MACEs) and chronic diseases was compared. RESULTS: A total of 74,367 gastric cancer survivors were matched (gastrectomy 49,578; ER 24,789). The gastrectomy group had lower incidence of hypertension (hazard ratio [HR] 0.53, p < 0.001; 11,757 events), ischemic heart disease (HR 0.80, p < 0.001; 4,740 events), heart failure (HR 0.77, p < 0.001; 5,580 events), cerebrovascular diseases (HR 0.78, p < 0.001; 6,013 events), and obesity-related cancers (HR 0.74, p < 0.001; 1,500 events). They also showed lower risk of death from obesity-related cancers (HR 0.74, p < 0.001) but higher risk of death by respiratory diseases (HR 1.37, p < 0.001). MACE-3 and MACE-6 were lower in the gastrectomy group (HR 0.86, p < 0.001). Average annual medical expenses for hypertension and diabetes within the first 10 years posttreatment were lower in the gastrectomy group ($90.3 ± 1.9 vs $118.4 ± 2.5, p < 0.001). CONCLUSIONS: The gastrectomy group exhibited lower risk of MACE, reduced incidence and mortality of obesity-related cancers, and lower medical expenses for diabetes or hypertension compared with the ER group, despite higher risk of respiratory disease-related death.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Woo HT, Kang SH, Baek JY, et al. Long-Term Survivorship after Gastrectomy or Endoscopic Resection for Gastric Cancer Using Nationwide Real-World Data. J Am Coll Surg. 2025. PMID: 40492628. doi:10.1097/XCS.0000000000001479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。